SION — Sionna Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $1.91bn
- $1.66bn
- 27
- 26
- 95
- 47
Annual cashflow statement for Sionna Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -40.2 | -47.3 | -61.7 |
| Depreciation | |||
| Non-Cash Items | 1.29 | 3.76 | 11.3 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 2.76 | -0.783 | -3.08 |
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | -36.1 | -43.7 | -52.8 |
| Capital Expenditures | -1.87 | -1.12 | -0.027 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -27.4 | 28.5 | -127 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -29.3 | 27.4 | -127 |
| Financing Cash Flow Items | — | — | -2.5 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 111 | 0.031 | 179 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 45.5 | -16.3 | -0.733 |